Andrew S. Davis - Mar 2, 2022 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Role: Chief Commercial Officer
Signature: /s/Mhairi Jones, by power of attorney
Stock symbol: SILK
Transactions as of: Mar 2, 2022
Transactions value $: -$46,704
Form type: 4
Date filed: 3/4/2022, 05:39 PM
Previous filing: Nov 2, 2021
Next filing: Jul 7, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SILK	Common Stock	Award	$0	+34.8K	+49.56%	$0.00	105K	Mar 2, 2022	Direct	F1
transaction	SILK	Common Stock	Tax liability	-$46.7K	-1.3K	-1.23%	$36.06	104K	Mar 3, 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SILK	Option (right to buy)	Award	$0	+31.8K		$0.00	31.8K	Mar 2, 2022	Common Stock	31.8K	$37.07	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. 25% of the shares shall vest on March 1, 2023 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2	Represents shares that have been sold by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.
F3	One forty-eighth of the shares subject to the option shall vest on April 1, 2022 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.